RPS14 and neoplasm: OncoVEX is a second-generation oncolytic HSV-1 with deletion in ICP34.5 to provide tumour selective replication [21,22] and deletion of ICP47 resulting in the expression of the US11 gene as an immediate-early (IE) rather than a late (L) gene to further increase tumour replication [23].